Evidence of gadolinium deposits in neuronal tissues following intravenous (IV) gadolinium-based contrast agents have been found, researchers from the Mayo Clinic reported. Findings have been published ...
Mason Frazier, M.D., associate professor in the University of Alabama at Birmingham’s Marnix E. Heersink School of Medicine’s Department of Radiology, says contrast imaging is important part of ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...
Problem: Recently, the Centers for Disease Control and Prevention (CDC) reiterated its position calling for medications labeled as "single dose" or "single use" to be ...
(RTTNews) - GE Healthcare said Monday that the U.S. Food and Drug Administration approved Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio ...
Contrast-enhanced mammography is a new imaging test that uses an IV contrast injection to help doctors detect breast cancer earlier in women with dense breasts. Why Elon Musk says saving for ...
Some medications must be given by an intravenous (IV) injection or infusion. This means they’re sent directly into your vein using a needle or tube. In fact, the term “intravenous” means “into the ...
Berlex Laboratories has issued a nationwide recall of its intravenous X-ray contrast agent because some vials crystallized prior to injection. The voluntary recall, which affects a single lot of the ...
Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products “The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results